The independent home of the case method - and a charity. Make an impact and  donate

Product details

Product details
By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

Merck, voted as America''s most admired company by Fortune for seven consecutive years (between 1986 and 1993), was facing a host of problems by 2003. Known for its pioneering research in the pharmaceutical industry in the past, Merck had introduced only six drugs between 2001 and 2003. The company''s sales have also declined taking it to the number three position in the global pharmaceutical industry. Its net income fell for two consecutive years between 2002 and 2003 and it had to lay off 4,400 employees, the biggest ever in its 117 year history, in 2003. The case focuses on the reasons behind Merck''s decline and prompts a discussion on how competitive Merck can be in the future.
Location:
Other setting(s):
2004

About

Abstract

Merck, voted as America''s most admired company by Fortune for seven consecutive years (between 1986 and 1993), was facing a host of problems by 2003. Known for its pioneering research in the pharmaceutical industry in the past, Merck had introduced only six drugs between 2001 and 2003. The company''s sales have also declined taking it to the number three position in the global pharmaceutical industry. Its net income fell for two consecutive years between 2002 and 2003 and it had to lay off 4,400 employees, the biggest ever in its 117 year history, in 2003. The case focuses on the reasons behind Merck''s decline and prompts a discussion on how competitive Merck can be in the future.

Settings

Location:
Other setting(s):
2004

Related